BDX

Baxter lifts its 2026 sales and earnings outlook after a strong Q2, but notes that manufacturing costs, tariffs and pricing pressure could squeeze margins. The company sees growth offsetting some cost headwinds.

This week’s dividend updates cover changes for Dividend Champions, Contenders, and Challengers, including upcoming ex‑dividend and pay dates.

Becton, Dickinson and Company has outperformed the medical devices industry over the past year, and analysts remain cautiously optimistic about its prospects.

Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns. Here are the four names that made it happen and whether their income streaks can survive what comes next.